Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K

Jessie Villanueva(The Wistar Institute), Adina Vultur(The Wistar Institute), John Tayu Lee(The Wistar Institute), Rajasekharan Somasundaram(The Wistar Institute), Mizuho Fukunaga‐Kalabis(The Wistar Institute), Angela K. Cipolla(The Wistar Institute), Bradley Wubbenhorst(University of Pennsylvania), Xiaowei Xu(University of Pennsylvania), Phyllis A. Gimotty(University of Pennsylvania), Damien Kee(Peter MacCallum Cancer Centre), Ademi Santiago-Walker(The Wistar Institute), Richard Letrero(University of Pennsylvania), Kurt D’Andrea(University of Pennsylvania), Anitha Pushparajan(University of Pennsylvania), James E. Hayden(The Wistar Institute), Kimberly Dahlman Brown(Vanderbilt University Medical Center), Sylvie Laquerre(GlaxoSmithKline (United States)), Grant A. McArthur(Peter MacCallum Cancer Centre), Jeffrey A. Sosman(Vanderbilt University Medical Center), Katherine L. Nathanson(University of Pennsylvania), Meenhard Herlyn(The Wistar Institute)
Cancer Cell
December 1, 2010
10.1016/j.ccr.2010.11.023
Cited by 1,231Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis